Co-Diagnostics, Inc.(NasdaqCM:CODX) dropped from S&P Global BMI Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.1 USD | +0.92% | +2.33% | -17.29% |
13/05 | HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $2.50, Maintains Neutral Rating | MT |
09/05 | Transcript : Co-Diagnostics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.29% | 3.44Cr | |
-18.97% | 1.82TCr | |
-42.48% | 283.89Cr | |
+22.69% | 194.46Cr | |
-1.56% | 164.25Cr | |
+32.98% | 133.02Cr | |
-17.41% | 95Cr | |
-22.25% | 89Cr | |
+10.31% | 87Cr | |
-26.78% | 61Cr |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- Co-Diagnostics, Inc.(NasdaqCM: CODX) dropped from S&P Global BMI Index